497 related articles for article (PubMed ID: 9217054)
1. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
[TBL] [Abstract][Full Text] [Related]
2. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Grieder FB; Vogel SN
Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
[TBL] [Abstract][Full Text] [Related]
3. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
[TBL] [Abstract][Full Text] [Related]
4. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
[TBL] [Abstract][Full Text] [Related]
5. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages.
Grieder FB; Nguyen HT
Microb Pathog; 1996 Aug; 21(2):85-95. PubMed ID: 8844652
[TBL] [Abstract][Full Text] [Related]
6. [Increase of interleukin-1 beta, gamma interferon and tumor necrosis factor alpha in serum and brain of mice infected with the Venezuelan Equine Encephalitis virus].
Valerol N; Bonilla E; Espina LM; Maldonado M; Montero E; Añez F; Levy A; Bermudez J; Meleán E; Nery A
Invest Clin; 2008 Dec; 49(4):457-67. PubMed ID: 19245165
[TBL] [Abstract][Full Text] [Related]
7. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
[TBL] [Abstract][Full Text] [Related]
9. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
10. Tunicamycin enhances neuroinvasion and encephalitis in mice infected with Venezuelan equine encephalitis virus.
Steele KE; Seth P; Catlin-Lebaron KM; Schoneboom BA; Husain MM; Grieder F; Maheshwari RK
Vet Pathol; 2006 Nov; 43(6):904-13. PubMed ID: 17099147
[TBL] [Abstract][Full Text] [Related]
11. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice.
Schoneboom BA; Lee JS; Grieder FB
J Interferon Cytokine Res; 2000 Feb; 20(2):205-15. PubMed ID: 10714557
[TBL] [Abstract][Full Text] [Related]
12. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
14. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
White LJ; Wang JG; Davis NL; Johnston RE
J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360
[TBL] [Abstract][Full Text] [Related]
15. Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus.
Valero N; MarinaEspina L; Bonilla E; Mosquera J
J Pineal Res; 2007 Mar; 42(2):107-12. PubMed ID: 17286740
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity.
Ehlers S; Mielke ME; Blankenstein T; Hahn H
J Immunol; 1992 Nov; 149(9):3016-22. PubMed ID: 1401926
[TBL] [Abstract][Full Text] [Related]
17. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse.
Charles PC; Trgovcich J; Davis NL; Johnston RE
Virology; 2001 Jun; 284(2):190-202. PubMed ID: 11384219
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
19. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN
Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507
[TBL] [Abstract][Full Text] [Related]
20. [Up-to-date understanding of tuberculosis immunity].
Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
